Sort by
Refine Your Search
-
Materials science and technology are our passion. With our cutting-edge research, Empa's around 1,100 employees make essential contributions to the well-being of society for a future worth living. Empa is a research institution of the ETH Domain. The project will mainly be carried out in...
-
8 Mar 2025 Job Information Organisation/Company Empa Research Field Chemistry » Other Computer science » Informatics Computer science » Programming Computer science » Other Engineering » Electrical
-
innovative deposition processes and high-throughput materials screening. The opportunity: Contribute to groundbreaking research on UV-resilient transparent conductive materials for photovoltaic technologies
-
8 Mar 2025 Job Information Organisation/Company Empa Research Field Computer science » Programming Engineering » Materials engineering Engineering » Mechanical engineering Engineering » Other
-
. Empa is a research institution of the ETH Domain. Dual-comb spectroscopy (DCS) is a rapidly evolving techniques opening up new fields of applications. Our aim is to leverage on quantum cascade laser (QCL
-
research at the interface of modeling and simulation of laser manufacturing processes (e.g., laser cladding, additive manufacturing) and experimental validation using advanced facilities (high-speed optical
-
robotics and a proactive approach to exploring new technologies. Fluency in French and/or German. Our offer We offer a fully funded 1 year post-doc position with the possibility of extension at Empa
-
field High motivation to work in an interdisciplinary project Extensive experience with advanced cell/tissue culture work Expertise in the field of (nano)toxicology Basic knowledge in transcriptomics
-
is a plus You like to work interdisciplinary and publish your results for the scientific community Fluency in English, further knowledge of German is a plus Our offer We offer an international, highly
-
for high impact research. We have internal expertise in (micro)biology, chemistry, materials engineering and ex vivo models, and we have strong collaborators with external academic, industrial and clinical